Quantitative Cardiac Parametric Mapping

Description

The overall goal of this project is to evaluate the clinical potential of fast quantitative myocardial tissue characterization using recently emerged Cardiac Magnetic Resonance Imaging (CMR) techniques to aid the diagnosis, treatment, and follow up of patients with myocardial diseases, such as ischemic heart disease, cardiomyopathies, and myocarditis.

Conditions

Cardiomyopathy, Myocarditis, Ischemic Heart Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

The overall goal of this project is to evaluate the clinical potential of fast quantitative myocardial tissue characterization using recently emerged Cardiac Magnetic Resonance Imaging (CMR) techniques to aid the diagnosis, treatment, and follow up of patients with myocardial diseases, such as ischemic heart disease, cardiomyopathies, and myocarditis.

Novel Magnetic Resonance Imaging Techniques for Quantitative Cardiac Parametric Mapping

Quantitative Cardiac Parametric Mapping

Condition
Cardiomyopathy, Myocarditis, Ischemic Heart Disease
Intervention / Treatment

-

Contacts and Locations

Charleston

Medical University of South Carolina, Charleston, South Carolina, United States, 29425

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Subject must be 18-90 years of age.
  • * Subject must be previously diagnosed with or suspected to have one of the following conditions.
  • * Myocardial ischemia or infarction (group 1)
  • * Hypertrophic cardiomyopathy (group 2)
  • * Infiltrative cardiomyopathy (group 3)
  • * Myocarditis (group 4)
  • * Subject must have been referred for a clinically indicated CMR.
  • * Subject has any implanted device or condition in which an MR scan would be contraindicated.
  • * Subject has an acute psychiatric disorder or is cognitively impaired.
  • * Subject is using or is dependent on substances of abuse.
  • * Subject is unwilling to comply with the requirements of the protocol.
  • * Subject has previously entered this study.
  • * Subject has an allergy against MRI contrast agents.
  • * Subject is in acute unstable condition.

Ages Eligible for Study

18 Years to 90 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Medical University of South Carolina,

Joseph U. Schoepf, MD, PRINCIPAL_INVESTIGATOR, Medical University of South Carolina

Study Record Dates

2025-12